The Journal of Heart and Lung Transplantation
Volume 27, Issue 5 , Pages 486-493 , May 2008

Outcome of Heart Transplants 15 to 20 Years Ago: Graft Survival, Post-transplant Morbidity, and Risk Factors for Mortality

  • Jean C. Roussel, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Nantes Hospital University, Nantes, France
    • Thoracic Transplantation Unit, Nantes Hospital University, Nantes, France
    • Corresponding Author InformationReprint requests: Jean Christian Roussel, Institut du Thorax, Chirurgie Thoracique et CardioVasculaire, CHU Nord, Boulevard Jacques Monod, Saint Herblain, 44093 Nantes Cedex 1, France. Telephone: 003-336-815-16773. Fax: 003-332-401-65402.
    • ,
  • Olivier Baron, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Nantes Hospital University, Nantes, France
    • Thoracic Transplantation Unit, Nantes Hospital University, Nantes, France
    • ,
  • Christian Périgaud, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Nantes Hospital University, Nantes, France
    • Thoracic Transplantation Unit, Nantes Hospital University, Nantes, France
    • ,
  • Philippe Bizouarn, MD

      Affiliations

    • Department of Anesthesiology, Nantes Hospital University, Nantes, France.
    • ,
  • Sabine Pattier, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Nantes Hospital University, Nantes, France
    • Thoracic Transplantation Unit, Nantes Hospital University, Nantes, France
    • ,
  • Oussama Habash, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Nantes Hospital University, Nantes, France
    • Thoracic Transplantation Unit, Nantes Hospital University, Nantes, France
    • ,
  • Antoine Mugniot, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Nantes Hospital University, Nantes, France
    • Thoracic Transplantation Unit, Nantes Hospital University, Nantes, France
    • ,
  • Thierry Petit, MD

      Affiliations

    • Thoracic Transplantation Unit, Nantes Hospital University, Nantes, France
    • ,
  • Jean L. Michaud, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Nantes Hospital University, Nantes, France
    • Thoracic Transplantation Unit, Nantes Hospital University, Nantes, France
    • ,
  • Marie Françoise Heymann, MD

      Affiliations

    • Thoracic Transplantation Unit, Nantes Hospital University, Nantes, France
    • ,
  • Michèle Treilhaud, MD

      Affiliations

    • Thoracic Transplantation Unit, Nantes Hospital University, Nantes, France
    • Department of Anesthesiology, Nantes Hospital University, Nantes, France.
    • ,
  • Jean N. Trochu, MD, PhD

      Affiliations

    • Thoracic Transplantation Unit, Nantes Hospital University, Nantes, France
    • Department of Cardiology, Nantes Hospital University, Nantes, France
    • ,
  • Jean P. Gueffet, MD

      Affiliations

    • Thoracic Transplantation Unit, Nantes Hospital University, Nantes, France
    • Department of Cardiology, Nantes Hospital University, Nantes, France
    • ,
  • Guillaume Lamirault, MD

      Affiliations

    • Thoracic Transplantation Unit, Nantes Hospital University, Nantes, France
    • Department of Cardiology, Nantes Hospital University, Nantes, France
    • ,
  • Daniel Duveau, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Nantes Hospital University, Nantes, France
    • Thoracic Transplantation Unit, Nantes Hospital University, Nantes, France
    • ,
  • Philippe Despins, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Nantes Hospital University, Nantes, France
    • Thoracic Transplantation Unit, Nantes Hospital University, Nantes, France

Received 16 July 2007 ,Revised 10 November 2007 ,Accepted 13 January 2008.

References 

  1. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report--2006. J Heart Lung Transplant. 2006;25:869–879
  2. Renlund DG, Taylor DO, Kfoury AG, Shaddy RS. New UNOS rules: historical background and implications for transplantation management (United Network for Organ Sharing). J Heart Lung Transplant. 1999;18:1065–1070
  3. Lower RR SN. Studies on the orthotopic homotransplantation of the canine heart. Surg Forum. 1960;11:
  4. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group (The International Society for Heart Transplantation). J Heart Transplant. 1990;9:587–593
  5. John R, Rajasinghe HA, Chen JM, et al. Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy. Ann Thorac Surg. 2001;72:440–449
  6. Fraund S, Pethig K, Franke U, et al. Ten year survival after heart transplantation: palliative procedure or successful long term treatment?. Heart. 1999;82:47–51
  7. Ozduran V, Yamani MH, Chuang HH, et al. Survival beyond 10 years following heart transplantation: The Cleveland Clinic Foundation experience. Transplant Proc. 2005;37:4509–4512
  8. Kirsch M, Baufreton C, Naftel DC, Benvenuti C, Loisance DY. Pretransplantation risk factors for death after heart transplantation: the Henri Mondor experience. J Heart Lung Transplant. 1998;17:268–277
  9. Walley VM, Masters RG, Boone SA, et al. Analysis of deaths after heart transplantation: the University of Ottawa Heart Institute experience. J Heart Lung Transplant. 1993;12:790–801
  10. Gallo PAL, Angelini A, et al. Causes of late failure after heart transplantation: a ten-year survey. J Heart Lung Transplant. 1997;16:1113–1121
  11. Kirklin JK, Naftel DC, Bourge RC, et al. Evolving trends in risk profiles and causes of death after heart transplantation: a ten-year multi-institutional study. J Thorac Cardiovasc Surg. 2003;125:881–890
  12. Cole WH. The increase in immunosuppression and its role in the development of malignant lesions. J Surg Oncol. 1985;30:139–144
  13. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JP. Risk of neoplasia in renal transplant patients. Lancet. 1995;346:403–406
  14. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl. 1994;99–109
  15. Mihalov MGP, Abraham K, Holmes EW, Reddy V. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant. 1996;10:248–255
  16. El-Hamamsy I, Stevens LM, Carrier M, et al. Incidence and prognosis of cancer following heart transplantation using RATG induction therapy. Transpl Int. 2005;18:1280–1285
  17. Rinaldi M, Pellegrini C, D'Armini AM, et al. Neoplastic disease after heart transplantation: single center experience. Eur J Cardiothorac Surg. 2001;19:696–701
  18. Olivari MT, Diekmann RA, Kubo SH, Braunlin E, Jamieson SW, Ring WS. Low incidence of neoplasia in heart and heart-lung transplant recipients receiving triple-drug immunosuppression. J Heart Transplant. 1990;9:618–621
  19. Dresdale AR LS, Drost C, Levine TB, Fenn N, Paone G, Del Busto R, et al. Propective evaluation of malignant neoplasms in cardiac transplant recipients uniformly treated with prophylactic antilymphocyte globulin. J Thorac Cardiovasc Surg. 1993;106:1202–1207
  20. Pham SM, Kormos RL, Landreneau RJ, et al. Solid tumors after heart transplantation: lethality of lung cancer. Ann Thorac Surg. 1995;60:1623–1626
  21. Dantal J, Hourmant M, Cantarovich D, et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens (PG - 623–8). Lancet. 1998;351:623–628
  22. Gaya SB, Rees AJ, Lechler RI, Williams G, Mason PD. Malignant disease in patients with long-term renal transplants. Transplantation. 1995;59:1705–1709
  23. Caforio AL, Fortina AB, Piaserico S, et al. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation. 2000;102:III222–III227
  24. Sheil AG, Disney AP, Mathew TH, Amiss N. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc. 1993;25:1383–1384
  25. Gao SZ, Chaparro SV, Perlroth M, et al. Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University. J Heart Lung Transplant. 2003;22:505–514
  26. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993;342:1514–1516
  27. Al Aly Z, Abbas S, Moore E, Diallo O, Hauptman PJ, Bastani B. The natural history of renal function following orthotopic heart transplant. Clin Transplant. 2005;19:683–689
  28. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349:931–940
  29. Hendawy A, Pouteil-Noble C, Villar E, Boissonnat P, Sebbag L. Chronic renal failure and end-stage renal disease are associated with a high rate of mortality after heart transplantation. Transplant Proc. 2005;37:1352–1354
  30. Shiba N, Chan MC, Kwok BW, Valantine HA, Robbins RC, Hunt SA. Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience. J Heart Lung Transplant. 2004;23:155–164
  31. Baron O, Trochu JN, Treilhaud M, et al. Cardiac transplantation in patients over 60 years of age. Transplant Proc. 1999;31:75–78
  32. Baron O, Le Guyader A, Trochu JN, et al. Does the pretransplant UNOS status modify the short- and long-term cardiac transplant prognosis?. Ann Thorac Surg. 2003;75:1878–1885
  33. Sung RS, Althoen M, Howell TA, Ojo AO, Merion RM. Excess risk of renal allograft loss associated with cigarette smoking. Transplantation. 2001;71:1752–1757
  34. Martin JC, Hathaway DK, Egidi MF, Gaber AO. Lifestyle behaviors affect cardiovascular risk status in men 1 year after kidney transplantation. Clin Transplant. 2001;15(suppl 6):41–45
  35. Ramsay HM, Fryer AA, Reece S, Smith AG, Harden PN. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis. 2000;36:167–176
  36. Radovancevic B, Poindexter S, Birovljev S, et al. Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients. Eur J Cardiothorac Surg. 1990;4:309–312discussion 313
  37. Pungpapong S, Manzarbeitia C, Ortiz J, et al. Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation. Liver Transpl. 2002;8:582–587
  38. Arcasoy SM, Hersh C, Christie JD, et al. Bronchogenic carcinoma complicating lung transplantation. J Heart Lung Transplant. 2001;20:1044–1053
  39. Pollard JD, Hanasono MM, Mikulec AA, Le QT, Terris DJ. Head and neck cancer in cardiothoracic transplant recipients. Laryngoscope. 2000;110:1257–1261
  40. Nagele H, Kalmar P, Rodiger W, Stubbe HM. Smoking after heart transplantation: an underestimated hazard?. Eur J Cardiothorac Surg. 1997;12:70–74

PII: S1053-2498(08)00047-8

doi: 10.1016/j.healun.2008.01.019

The Journal of Heart and Lung Transplantation
Volume 27, Issue 5 , Pages 486-493 , May 2008

Article Tools

* Image Usage & Resolution